Primary malignant skin tumors in children : Etiology, treatment and prognosis
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-12-01
著者
-
Varan Ali
Department Of Pediatric Oncology Institute Of Oncology Hacettepe University
-
Varan Ali
Department Of Pediatric Oncology Hacettepe University Institute Of Oncology Hacettepe Universty Medi
-
Kutluk Tezer
Department Of Pediatric Oncology Hacettepe University Institute Of Oncology
-
KOKSAL YAVUZ
Department of Pediatric Oncology, Institute of Oncology, Hacettepe University
-
AKYUZ CANAN
Department of Pediatric Oncology, Institute of Oncology, Hacettepe University
-
Kutluk Tezer
Department Of Pediatric Oncology Faculty Of Medicine Hacettepe University
-
Koksal Yavuz
Department Of Pediatric Oncology Institute Of Oncology Hacettepe University
-
Akyuz Canan
Department Of Pediatric Oncology Institute Of Oncology Hacettepe University
-
Buyukpamukcu Munevver
Department Of Pediatric Oncology Institute Of Oncology Hacettepe University
-
Buyukpamukcu Munevver
Department Of Pediatric Oncology Faculty Of Medicine Hacettepe University
-
GOKOZ AYTAC
Department of Pathology, Hacettepe University, Faculty of Medicine
-
YALCIN BILGEHAN
Department of Pediatric Oncology, Hacettepe University, Institute of Oncology
-
Yalcin Bilgehan
Department Of Pediatric Oncology Hacettepe University Institute Of Oncology
-
Gokoz Aytac
Department Of Pathology Hacettepe University Faculty Of Medicine
関連論文
- Malignant mesothelioma in an adolescent boy
- Teratoid Wilms' tumor in a child
- Neurofibroma Adjacent to the Thyroid Gland and a Thyroid Papillary Carcinoma in a Patient with Neurofibromatosis Type 1 : Report of a Case
- Importance of chemoprophylaxis and vaccines in the prevention of recurrent meningitis
- Primary malignant skin tumors in children : Etiology, treatment and prognosis
- Successful treatment of Epstein-Barr virus infection associated with myocarditis
- Re-evaluation of Axillary Skip Metastases in the Era of Sentinel Lymph Node Biopsy in Breast Cancer
- Hepatic lobectomies in children : experience of a center in the light of changing management of malignant liver tumors